Publication | Closed Access

Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study

ThrombosisHypertensionCardiovascular DiseaseSingle AdministrationPharmacologyCardiologyPreventive CardiologyPublic HealthMedicineAtherosclerosisHmg-coa Reductase InhibitorCoronary Artery DiseaseAcute Myocardial InfarctionCardiovascular Imaging